PortfoliosLab logoPortfoliosLab logo
ARLO vs. ALHC
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ARLO vs. ALHC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Arlo Technologies, Inc. (ARLO) and Alignment Healthcare Holdings, LLC (ALHC). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ARLO achieves a -5.50% return, which is significantly lower than ALHC's 7.80% return.


ARLO

1D
1.23%
1M
0.46%
YTD
-5.50%
6M
-5.16%
1Y
-22.74%
3Y*
12.97%
5Y*
12.52%
10Y*

ALHC

1D
-2.61%
1M
30.21%
YTD
7.80%
6M
5.45%
1Y
52.51%
3Y*
51.69%
5Y*
-4.22%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

ARLO vs. ALHC - Yearly Performance Comparison


2026 (YTD)20252024202320222021
ARLO
Arlo Technologies, Inc.
-5.50%25.02%17.54%171.23%-66.54%43.90%
ALHC
Alignment Healthcare Holdings, LLC
7.80%75.56%30.66%-26.79%-16.36%-26.19%

Correlation

The correlation between ARLO and ALHC is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.19

Correlation (3Y)
Calculated over the trailing 3-year period

0.08

Correlation (5Y)
Calculated over the trailing 5-year period

0.19

Correlation (All Time)
Calculated using the full available price history since Mar 26, 2021

0.20

The correlation between ARLO and ALHC shifts across timeframes, from 0.08 (3 years) to 0.20 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

ARLO:

$1.46B

ALHC:

$4.54B

EPS

ARLO:

$0.28

ALHC:

$0.10

PE Ratio

ARLO:

47.31

ALHC:

222.93

PS Ratio

ARLO:

2.59

ALHC:

1.04

PB Ratio

ARLO:

9.16

ALHC:

21.93

Total Revenue (TTM)

ARLO:

$560.61M

ALHC:

$4.26B

Gross Profit (TTM)

ARLO:

$252.78M

ALHC:

$365.25M

EBITDA (TTM)

ARLO:

$26.66M

ALHC:

$66.34M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ARLO vs. ALHC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ARLO
ARLO Risk / Return Rank: 2222
Overall Rank
ARLO Sharpe Ratio Rank: 2222
Sharpe Ratio Rank
ARLO Sortino Ratio Rank: 2222
Sortino Ratio Rank
ARLO Omega Ratio Rank: 2323
Omega Ratio Rank
ARLO Calmar Ratio Rank: 2323
Calmar Ratio Rank
ARLO Martin Ratio Rank: 2323
Martin Ratio Rank

ALHC
ALHC Risk / Return Rank: 7070
Overall Rank
ALHC Sharpe Ratio Rank: 7171
Sharpe Ratio Rank
ALHC Sortino Ratio Rank: 6969
Sortino Ratio Rank
ALHC Omega Ratio Rank: 7171
Omega Ratio Rank
ALHC Calmar Ratio Rank: 6666
Calmar Ratio Rank
ALHC Martin Ratio Rank: 7171
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ARLO vs. ALHC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Arlo Technologies, Inc. (ARLO) and Alignment Healthcare Holdings, LLC (ALHC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ARLOALHCDifference
Sharpe ratioReturn per unit of total volatility

-1.40

Sortino ratioReturn per unit of downside risk

-2.03

Omega ratioGain probability vs. loss probability

0.95

1.23

-0.27

Calmar ratioReturn relative to maximum drawdown

-0.54

1.20

-1.74

Martin ratioReturn relative to average drawdown

-0.95

3.63

-4.58

ARLO vs. ALHC - Sharpe Ratio Comparison

The current ARLO Sharpe Ratio is -0.45, which is lower than the ALHC Sharpe Ratio of 0.95. The chart below compares the historical Sharpe Ratios of ARLO and ALHC, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

ARLO vs. ALHC - Drawdown Comparison

The maximum ARLO drawdown since its inception was -93.50%, which is greater than ALHC's maximum drawdown of -83.61%. Use the drawdown chart below to compare losses from any high point for ARLO and ALHC.


Loading charts...

Drawdown Indicators


ARLOALHCDifference

Max Drawdown

Largest peak-to-trough decline

-93.50%

-83.61%

-9.89%

Max Drawdown (1Y)

Largest decline over 1 year

-42.23%

-44.14%

+1.91%

Max Drawdown (3Y)

Largest decline over 3 years

-50.82%

-50.33%

-0.49%

Max Drawdown (5Y)

Largest decline over 5 years

-72.17%

-82.57%

+10.40%

Current Drawdown

Current decline from peak

-42.72%

-21.93%

-20.79%

Average Drawdown

Average peak-to-trough decline

-62.26%

-52.00%

-10.26%

Ulcer Index

Depth and duration of drawdowns from previous peaks

23.91%

14.52%

+9.39%

Volatility

ARLO vs. ALHC - Volatility Comparison

The current volatility for Arlo Technologies, Inc. (ARLO) is 11.17%, while Alignment Healthcare Holdings, LLC (ALHC) has a volatility of 29.89%. This indicates that ARLO experiences smaller price fluctuations and is considered to be less risky than ALHC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ARLOALHCDifference

Volatility (1M)

Calculated over the trailing 1-month period

11.17%

29.89%

-18.72%

Volatility (6M)

Calculated over the trailing 6-month period

39.57%

47.02%

-7.45%

Volatility (1Y)

Calculated over the trailing 1-year period

51.00%

55.83%

-4.83%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

61.42%

63.64%

-2.22%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

73.65%

63.90%

+9.75%

Dividends

ARLO vs. ALHC - Dividend Comparison

Neither ARLO nor ALHC has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

ARLO vs. ALHC - Financials Comparison

This section allows you to compare key financial metrics between Arlo Technologies, Inc. and Alignment Healthcare Holdings, LLC. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00200.00M400.00M600.00M800.00M1.00B1.20B20222023202420252026
150.38M
1.24B
(ARLO) Total Revenue
(ALHC) Total Revenue
Values in USD except per share items

ARLO vs. ALHC - Profitability Comparison

The chart below illustrates the profitability comparison between Arlo Technologies, Inc. and Alignment Healthcare Holdings, LLC over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%10.0%20.0%30.0%40.0%50.0%20222023202420252026
48.3%
0
Portfolio components
ARLO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Arlo Technologies, Inc. reported a gross profit of 72.67M and revenue of 150.38M. Therefore, the gross margin over that period was 48.3%.

ALHC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Alignment Healthcare Holdings, LLC reported a gross profit of 0.00 and revenue of 1.24B. Therefore, the gross margin over that period was 0.0%.

ARLO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Arlo Technologies, Inc. reported an operating income of 7.56M and revenue of 150.38M, resulting in an operating margin of 5.0%.

ALHC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Alignment Healthcare Holdings, LLC reported an operating income of 15.50M and revenue of 1.24B, resulting in an operating margin of 1.3%.

ARLO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Arlo Technologies, Inc. reported a net income of 14.88M and revenue of 150.38M, resulting in a net margin of 9.9%.

ALHC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Alignment Healthcare Holdings, LLC reported a net income of 11.42M and revenue of 1.24B, resulting in a net margin of 0.9%.


Frequently Asked Questions


ARLO and ALHC have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ALHC has higher volatility (29.89%) compared to ARLO (11.17%). In terms of maximum drawdown, ARLO dropped -93.50% vs ALHC's -83.61%.

ALHC currently has the higher Sharpe Ratio (0.95 vs -0.45), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ARLO and ALHC

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer